![2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure - - 2022 - European Journal of Heart Failure - Wiley Online Library 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure - - 2022 - European Journal of Heart Failure - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/0b5d7017-5559-41a7-a85c-cef2afe0a01f/ejhf2333-fig-0016-m.jpg)
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure - - 2022 - European Journal of Heart Failure - Wiley Online Library
![ACC/AHA/ACP-ASIM guidelines for the management of patients with chronic stable angina1: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients With ACC/AHA/ACP-ASIM guidelines for the management of patients with chronic stable angina1: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients With](https://www.jacc.org/cms/asset/21cca1a5-ca2a-42bf-a6c9-4554da4e0def/gr3.gif)
ACC/AHA/ACP-ASIM guidelines for the management of patients with chronic stable angina1: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients With
![2017 Comprehensive Update of the Canadian Cardiovascular Society Guidelines for the Management of Heart Failure - Canadian Journal of Cardiology 2017 Comprehensive Update of the Canadian Cardiovascular Society Guidelines for the Management of Heart Failure - Canadian Journal of Cardiology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/3343889e-e124-4bad-853f-d9774f96e3a6/gr1_lrg.jpg)
2017 Comprehensive Update of the Canadian Cardiovascular Society Guidelines for the Management of Heart Failure - Canadian Journal of Cardiology
![PDF) PART I: OPTIMIZATION OF HYDRALAZINE HYDROCHLORIDE IMMEDIATE RELEASE LAYER IN ANTIHYPERTENSIVE BILAYER TABLET PDF) PART I: OPTIMIZATION OF HYDRALAZINE HYDROCHLORIDE IMMEDIATE RELEASE LAYER IN ANTIHYPERTENSIVE BILAYER TABLET](https://i1.rgstatic.net/publication/344869596_PART_I_OPTIMIZATION_OF_HYDRALAZINE_HYDROCHLORIDE_IMMEDIATE_RELEASE_LAYER_IN_ANTIHYPERTENSIVE_BILAYER_TABLET/links/5f954fba92851c14bce56b0f/largepreview.png)
PDF) PART I: OPTIMIZATION OF HYDRALAZINE HYDROCHLORIDE IMMEDIATE RELEASE LAYER IN ANTIHYPERTENSIVE BILAYER TABLET
![PDF) The Endothelin Receptor Antagonist Macitentan Improves Isosorbide-5-Mononitrate (ISMN) and Isosorbide Dinitrate (ISDN) Induced Endothelial Dysfunction, Oxidative Stress, and Vascular Inflammation PDF) The Endothelin Receptor Antagonist Macitentan Improves Isosorbide-5-Mononitrate (ISMN) and Isosorbide Dinitrate (ISDN) Induced Endothelial Dysfunction, Oxidative Stress, and Vascular Inflammation](https://www.researchgate.net/publication/329969514/figure/fig4/AS:1086465257803839@1636044911837/Characterization-of-in-vitro-effects-of-macitentan-on-oxidative-burst-signals-of-isolated_Q320.jpg)